ArticleBMC cardiovascular disorders2026
Survival outcomes and predictors following coronary artery bypass grafting in patients with preoperative left ventricular dysfunction.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundLeft ventricular dysfunction (EF < 50%) is an independent risk factor for undergoing coronary artery bypass grafting (CABG), which has been shown to improve ejection fraction (EF) in patients with ischemic cardiomyopathy. However, whether the short-term improvement in EF can improve survival outcomes remains uncertain.
methodsIn this retrospective cohort study, we included patients with left ventricular ejection fraction (LVEF) < 50% undergoing CABG from 2013 to 2023. Clinical characteristics were extracted from the data registry. Univariate and multivariate logistic regression analyses identified independent predictors, while Kaplan-Meier analysis with log-rank test compared survival outcomes among LVEF-stratified subgroups.
resultsFrom 2013 to 2023, 362 patients (85.6% male; mean age 58.5) were enrolled. The 5-year Kaplan-Meier estimates for event-free and overall survival were 80.1% and 92.5%, respectively. Landmark analysis showed 72 (19.9%) patients experienced major adverse cardiovascular events, with significant differences between LVEF subgroups (improvement vs. non-improvement; p < 0.001). Multivariable logistic regression identified independent predictors of LVEF improvement: smoking status (p < 0.001), preoperative LVEF < 35% (p < 0.001), dyslipidemia (p = 0.012), and diseased coronary arteries (p < 0.001). Patients with postoperative EF improvement had significantly better overall survival (p < 0.001) and event-free survival (p < 0.001) than those without.
conclusionThe 5-year Kaplan-Meier estimates showed EF improvement early after CABG in patients with preoperative cardiac dysfunction predicted better survival. This highlights the need for closer postoperative monitoring and proactive management in this population. Additionally, interventions with proactive patient education should address factors causing postoperative LVEF non-improvement.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.